ID   FUCT1_HUMAN             Reviewed;         364 AA.
AC   Q96A29; B2RDB2; Q9BV76; Q9NUJ8;
DT   23-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   15-MAR-2017, entry version 147.
DE   RecName: Full=GDP-fucose transporter 1;
DE   AltName: Full=Solute carrier family 35 member C1;
GN   Name=SLC35C1; Synonyms=FUCT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CHARACTERIZATION, AND VARIANT
RP   CDG2C CYS-147.
RX   PubMed=11326279; DOI=10.1038/88289;
RA   Luehn K., Wild M.K., Eckhardt M., Gerardy-Schahn R., Vestweber D.;
RT   "The gene defective in leukocyte adhesion deficiency II encodes a
RT   putative GDP-fucose transporter.";
RL   Nat. Genet. 28:69-72(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS CDG2C CYS-147 AND
RP   ARG-308.
RX   PubMed=11326280; DOI=10.1038/88299;
RA   Luebke T., Marquardt T., Etzioni A., Hartmann E., von Figura K.,
RA   Koerner C.;
RT   "Complementation cloning identifies CDG-IIc, a new type of congenital
RT   disorders of glycosylation, as a GDP-fucose transporter deficiency.";
RL   Nat. Genet. 28:73-76(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Mammary gland, and Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   SER-49.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Involved in GDP-fucose import from the cytoplasm into
CC       the Golgi lumen.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane; Multi-pass
CC       membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96A29-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96A29-2; Sequence=VSP_047116;
CC   -!- DISEASE: Congenital disorder of glycosylation 2C (CDG2C)
CC       [MIM:266265]: A multisystem disorder caused by a defect in
CC       glycoprotein biosynthesis and characterized by under-glycosylated
CC       serum glycoproteins. Congenital disorders of glycosylation result
CC       in a wide variety of clinical features, such as defects in the
CC       nervous system development, psychomotor retardation, dysmorphic
CC       features, hypotonia, coagulation disorders, and immunodeficiency.
CC       The broad spectrum of features reflects the critical role of N-
CC       glycoproteins during embryonic development, differentiation, and
CC       maintenance of cell functions. The clinical features of CDG2C
CC       include mental retardation, short stature, facial stigmata, and
CC       recurrent bacterial peripheral infections with persistently
CC       elevated peripheral leukocytes. Biochemically, CDG2C is
CC       characterized by a lack of fucosylated glycoconjugates, including
CC       selectin ligands. {ECO:0000269|PubMed:11326279,
CC       ECO:0000269|PubMed:11326280}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the TPT transporter family. SLC35C
CC       subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA92126.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=SLC35C1base; Note=SLC35C1 mutation db;
CC       URL="http://structure.bmc.lu.se/idbase/SLC35C1base/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF323970; AAK50397.1; -; mRNA.
DR   EMBL; AF326199; AAK51705.1; -; mRNA.
DR   EMBL; AK027394; BAB55080.1; -; mRNA.
DR   EMBL; AK002182; BAA92126.1; ALT_INIT; mRNA.
DR   EMBL; AK315473; BAG37859.1; -; mRNA.
DR   EMBL; AC044839; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471064; EAW68031.1; -; Genomic_DNA.
DR   EMBL; BC001427; AAH01427.2; -; mRNA.
DR   CCDS; CCDS44575.1; -. [Q96A29-2]
DR   CCDS; CCDS7914.1; -. [Q96A29-1]
DR   RefSeq; NP_001138737.1; NM_001145265.1. [Q96A29-2]
DR   RefSeq; NP_001138738.1; NM_001145266.1. [Q96A29-2]
DR   RefSeq; NP_060859.4; NM_018389.4. [Q96A29-1]
DR   UniGene; Hs.12211; -.
DR   ProteinModelPortal; Q96A29; -.
DR   BioGrid; 120624; 1.
DR   STRING; 9606.ENSP00000313318; -.
DR   TCDB; 2.A.7.16.1; the drug/metabolite transporter (dmt) superfamily.
DR   iPTMnet; Q96A29; -.
DR   PhosphoSitePlus; Q96A29; -.
DR   SwissPalm; Q96A29; -.
DR   BioMuta; SLC35C1; -.
DR   DMDM; 20138280; -.
DR   MaxQB; Q96A29; -.
DR   PaxDb; Q96A29; -.
DR   PeptideAtlas; Q96A29; -.
DR   PRIDE; Q96A29; -.
DR   DNASU; 55343; -.
DR   Ensembl; ENST00000314134; ENSP00000313318; ENSG00000181830. [Q96A29-1]
DR   Ensembl; ENST00000442528; ENSP00000412408; ENSG00000181830. [Q96A29-2]
DR   GeneID; 55343; -.
DR   KEGG; hsa:55343; -.
DR   UCSC; uc001nbo.4; human. [Q96A29-1]
DR   CTD; 55343; -.
DR   DisGeNET; 55343; -.
DR   GeneCards; SLC35C1; -.
DR   HGNC; HGNC:20197; SLC35C1.
DR   HPA; HPA064001; -.
DR   MalaCards; SLC35C1; -.
DR   MIM; 266265; phenotype.
DR   MIM; 605881; gene.
DR   neXtProt; NX_Q96A29; -.
DR   OpenTargets; ENSG00000181830; -.
DR   Orphanet; 99843; Leukocyte adhesion deficiency type II.
DR   PharmGKB; PA134930330; -.
DR   eggNOG; KOG1442; Eukaryota.
DR   eggNOG; ENOG410XST0; LUCA.
DR   GeneTree; ENSGT00390000013315; -.
DR   HOGENOM; HOG000021132; -.
DR   HOVERGEN; HBG051670; -.
DR   InParanoid; Q96A29; -.
DR   KO; K15279; -.
DR   OMA; VVSLYWV; -.
DR   OrthoDB; EOG091G0CH6; -.
DR   PhylomeDB; Q96A29; -.
DR   TreeFam; TF354269; -.
DR   Reactome; R-HSA-6787639; GDP-fucose biosynthesis.
DR   Reactome; R-HSA-727802; Transport of nucleotide sugars.
DR   GeneWiki; SLC35C1; -.
DR   GenomeRNAi; 55343; -.
DR   PRO; PR:Q96A29; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000181830; -.
DR   CleanEx; HS_SLC35C1; -.
DR   ExpressionAtlas; Q96A29; baseline and differential.
DR   Genevisible; Q96A29; HS.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005457; F:GDP-fucose transmembrane transporter activity; TAS:Reactome.
DR   GO; GO:0008643; P:carbohydrate transport; IEA:UniProtKB-KW.
DR   GO; GO:0030259; P:lipid glycosylation; IEA:Ensembl.
DR   GO; GO:0045746; P:negative regulation of Notch signaling pathway; IEA:Ensembl.
DR   InterPro; IPR004853; Sugar_P_trans_dom.
DR   Pfam; PF03151; TPT; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome;
KW   Congenital disorder of glycosylation; Disease mutation;
KW   Golgi apparatus; Membrane; Polymorphism; Reference proteome;
KW   Sugar transport; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    364       GDP-fucose transporter 1.
FT                                /FTId=PRO_0000213391.
FT   TRANSMEM     34     56       Helical. {ECO:0000255}.
FT   TRANSMEM     76     98       Helical. {ECO:0000255}.
FT   TRANSMEM    111    130       Helical. {ECO:0000255}.
FT   TRANSMEM    140    162       Helical. {ECO:0000255}.
FT   TRANSMEM    167    185       Helical. {ECO:0000255}.
FT   TRANSMEM    195    214       Helical. {ECO:0000255}.
FT   TRANSMEM    227    249       Helical. {ECO:0000255}.
FT   TRANSMEM    264    286       Helical. {ECO:0000255}.
FT   VAR_SEQ       1     13       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_047116.
FT   VARIANT      49     49       W -> S (in dbSNP:rs11538193).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_057302.
FT   VARIANT     147    147       R -> C (in CDG2C; dbSNP:rs28939087).
FT                                {ECO:0000269|PubMed:11326279,
FT                                ECO:0000269|PubMed:11326280}.
FT                                /FTId=VAR_012347.
FT   VARIANT     240    240       I -> V (in dbSNP:rs7130656).
FT                                /FTId=VAR_057303.
FT   VARIANT     308    308       T -> R (in CDG2C; dbSNP:rs28937886).
FT                                {ECO:0000269|PubMed:11326280}.
FT                                /FTId=VAR_012348.
FT   CONFLICT    258    258       F -> L (in Ref. 3; BAA92126).
FT                                {ECO:0000305}.
SQ   SEQUENCE   364 AA;  39809 MW;  2E659D49C5C5E92E CRC64;
     MNRAPLKRSR ILHMALTGAS DPSAEAEANG EKPFLLRALQ IALVVSLYWV TSISMVFLNK
     YLLDSPSLRL DTPIFVTFYQ CLVTTLLCKG LSALAACCPG AVDFPSLRLD LRVARSVLPL
     SVVFIGMITF NNLCLKYVGV AFYNVGRSLT TVFNVLLSYL LLKQTTSFYA LLTCGIIIGG
     FWLGVDQEGA EGTLSWLGTV FGVLASLCVS LNAIYTTKVL PAVDGSIWRL TFYNNVNACI
     LFLPLLLLLG ELQALRDFAQ LGSAHFWGMM TLGGLFGFAI GYVTGLQIKF TSPLTHNVSG
     TAKACAQTVL AVLYYEETKS FLWWTSNMMV LGGSSAYTWV RGWEMKKTPE EPSPKDSEKS
     AMGV
//
